A set of gene variants that originated in Sub-Saharan West African populations may help explain why black women, compared to white women, have worse breast cancer outcomes, according to a new study from a team led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
The study, published April 3 in Cancer Epidemiology, Biomarkers & Prevention, found that higher amounts of the immune-related gene, DARC/ACKR1,...